retatrutide type 2 diabetes phase 2 results 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide Severe Obesity Trial Shows
Description
They're everywhere

Both drugs may cause mild but manageable GI side effects , such as nausea, vomiting, and diarrhea
What side effects should I expect on tirzepatide

The medication is typically initiated at a low dose and gradually titrated upward over several weeks to minimize gastrointestinal side effects such as nausea, vomiting, and diarrhea
00092-0/asset/9cb4d176-26e3-4508-8aa1-ecdb4e971f8d/main.assets/gr3_lrg.jpg)
Beware of prices significantly below $199 monthly or above $350 monthly, as these may indicate quality concerns or excessive markup respectively
